Abstract

The objective of the study was to develop and validate a prediction model that identifies COVID-19 patients at risk of requiring oxygen support based on five parameters: C-reactive protein (CRP), hypertension, age, and neutrophil and lymphocyte counts (CHANeL). This retrospective cohort study included 221 consecutive COVID-19 patients and the patients were randomly assigned randomly to a training set and a test set in a ratio of 1:1. Logistic regression, logistic LASSO regression, Random Forest, Support Vector Machine, and XGBoost analyses were performed based on age, hypertension status, serial CRP, and neutrophil and lymphocyte counts during the first 3 days of hospitalization. The ability of the model to predict oxygen requirement during hospitalization was tested. During hospitalization, 45 (41.8%) patients in the training set (n = 110) and 41 (36.9%) in the test set (n = 111) required supplementary oxygen support. The logistic LASSO regression model exhibited the highest AUC for the test set, with a sensitivity of 0.927 and a specificity of 0.814. An online risk calculator for oxygen requirement using CHANeL predictors was developed. “CHANeL” prediction models based on serial CRP, neutrophil, and lymphocyte counts during the first 3 days of hospitalization, along with age and hypertension status, provide a reliable estimate of the risk of supplement oxygen requirement among patients hospitalized with COVID-19.

Details

Title
Predication of oxygen requirement in COVID-19 patients using dynamic change of inflammatory markers: CRP, hypertension, age, neutrophil and lymphocyte (CHANeL)
Author
Lee, Eunyoung Emily 1 ; Hwang Woochang 2 ; Kyoung-Ho, Song 3   VIAFID ORCID Logo  ; Jung Jongtak 3 ; Kang, Chang Kyung 4   VIAFID ORCID Logo  ; Jeong-Han, Kim 5 ; Oh, Hong Sang 5 ; Kang, Yu Min 6 ; Lee, Eun Bong 7 ; Chin, Bum Sik 8 ; Song Woojeung 9 ; Kim, Nam Joong 4 ; Park, Jin Kyun 7 

 Eulji University School of Medicine, Division of Rheumatology, Department of Internal Medicine, Uijeongbu Eulji Medical Center, Uijeongbu-Si, South Korea (GRID:grid.255588.7) (ISNI:0000 0004 1798 4296) 
 Hanyang University, Hanyang Biomedical Research Institute, Seoul, South Korea (GRID:grid.49606.3d) (ISNI:0000 0001 1364 9317) 
 Seoul National University Bundang Hospital, Division of Infectious Diseases, Department of Internal Medicine, Seongnam, South Korea (GRID:grid.412480.b) (ISNI:0000 0004 0647 3378) 
 Seoul National University College of Medicine, Division of Infectious Diseases, Department of Internal Medicine, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Armed Forces Capital Hospital, Division of Infectious Diseases, Department of Internal Medicine, Seongnam-Si, South Korea (GRID:grid.413897.0) (ISNI:0000 0004 0624 2238) 
 Myongji Hospital, Department of Infectious Diseases, Goyang, South Korea (GRID:grid.416355.0) (ISNI:0000 0004 0475 0976); Seoul National University College of Medicine, Department of Medical Education, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University Hospital and Seoul National University College of Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 National Medical Center, Division of Infectious Diseases, Department of Internal Medicine, Seoul, South Korea (GRID:grid.415619.e) (ISNI:0000 0004 1773 6903) 
 Hanyang University, Department of Medicine, Major in Medical Genetics, Graduate School, Seoul, South Korea (GRID:grid.49606.3d) (ISNI:0000 0001 1364 9317) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2543894593
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.